---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-013107"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2024-10-18T23:59:59+00:00"
generated_at: "2026-05-30T12:42:42.586928+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Zivo Bioscience sells 169,022 unregistered shares at avg $10.44 to accredited investors

## Summary
- Sold 169,022 shares between Aug 22 and Oct 17, 2024, at $8.34 to $16.31 per share (avg $10.44).
- Of total, 52,802 shares sold to related parties at avg $9.68 per share.
- No solicitation or underwriting discounts; exempt under Section 4(a)(2) and Regulation D.
- As of Oct 17, 2024, outstanding shares total 3,535,134 (dilution ~4.8% from offering).
- Proceeds used for general corporate purposes (not stated, typical for such offerings).

## SEC filing metadata
- accession: 0001654954-24-013107
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2024-10-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495424013107/0001654954-24-013107-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495424013107/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-013107
- JSON: https://secwatch.observer/filing/0001654954-24-013107.json
- Plain text: https://secwatch.observer/filing/0001654954-24-013107.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.